Stevenage, United Kingdom

Suzanne Elaine Keeling

USPTO Granted Patents = 21 


 

Average Co-Inventor Count = 7.0

ph-index = 5

Forward Citations = 164(Granted Patents)


Location History:

  • Stevenage, Herfordshire, GB (2003)
  • Stevenage, GB (2002 - 2021)

Company Filing History:


Years Active: 2002-2021

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Suzanne Elaine Keeling

Introduction: Suzanne Elaine Keeling is a notable inventor based in Stevenage, GB, known for her extensive contributions to the field of biochemistry and pharmaceuticals. With a remarkable portfolio of 20 patents, her innovations are focused primarily on compounds that act as inhibitors of kinase activity, a critical area of research in the development of treatments for various diseases.

Latest Patents: Among her latest patents, Suzanne's work revolves around compounds of formula (I) and their salts. These compounds are specifically designed to inhibit PI3-kinase activity, which is significant for various therapeutic applications. Her repeated focus on this chemical pathway highlights her dedication to advancing medical science and providing possible solutions for chronic conditions.

Career Highlights: Suzanne Elaine Keeling has made significant strides in her career, particularly during her tenure at renowned companies such as Glaxo Group Limited and GlaxoSmithKline Intellectual Property Development Limited. Her involvement in these organizations has allowed her to work on groundbreaking projects that have shaped her expertise in the pharmaceutical industry.

Collaborations: Throughout her career, Suzanne has collaborated with esteemed colleagues such as Julie Nicole Hamblin and Paul Spencer Jones. These partnerships have facilitated knowledge exchange and innovation, contributing to the successful development of her patented compounds and enhancing research efforts within their respective fields.

Conclusion: Suzanne Elaine Keeling's contributions to the field of biochemistry through her patents underscore her status as a leading inventor in the industry. With her focus on kinase inhibitors, she continues to pave the way for new therapeutic advancements that have the potential to significantly impact healthcare and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…